{
  "ticker": "OSL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967805",
  "id": "02967805",
  "pages": 6,
  "price_sensitive": false,
  "date": "20250709",
  "time": "1348",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250709/pdf/06lmyw391hd9t2.pdf",
  "summary": "**Summary of ASX Announcement - Appendix 3B (Proposed Issue of Securities):**  \n\n- **Issue Type:** Placement (director participation)  \n- **Securities Issued:**  \n  - **Ordinary Shares (OSL):** 17,271 fully paid shares  \n  - **Attaching Options:** 17,271 options (expiry 31-Jul-2027, exercise price AUD 1.20)  \n- **Issue Price:** AUD 1.158 per share  \n- **Approval:** Shareholder approval received at EGM (8-Jul-2025)  \n- **Purpose:** Funds for clinical trials, administration, and working capital.  \n- **Issue Date:** 8-Aug-2025  \n\n*Other details (underwriting, escrow, fees) not material or disclosed as \"No\".*",
  "usage": {
    "prompt_tokens": 2173,
    "completion_tokens": 176,
    "total_tokens": 2349,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-09T04:46:39.892204"
}